RelA Is an Essential Target for Enhancing Cellular Responses to the DNA Repair/Ref-1 Redox Signaling Protein and Restoring Perturbated Cellular Redox Homeostasis in Mouse PDAC Cells

Overview of attention for article published in Frontiers in oncology, March 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 18 news stories from 13 outlets.

Ocuphire Pharma Announces Financial Results for the Second Quarter 2022 and Provides Corporate Update Completed Final Clinical…

Completed Final Clinical Trials and Pre-NDA FDA Meeting to Support Registration of Nyxol in Reversal of Mydriasis (RM), On…

GlobeNewswire 2022-08-12 Completed Final Clinical Trials and Pre-NDA FDA Meeting to Support Registration of Nyxol in Reversal…

Completed Final Clinical Trials and Pre-NDA FDA Meeting to Support Registration of Nyxol in Reversal of Mydriasis (RM), On…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 14 additional news stories.